Aurinia Pharmaceuticals Inc banner

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 15.35 USD 0.72% Market Closed
Market Cap: $2B

Dividends

Aurinia Pharmaceuticals Inc
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Aurinia Pharmaceuticals Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Aurinia Pharmaceuticals Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

AUPH Price
Aurinia Pharmaceuticals Inc

Annual Price Range
15.35
52w Low
8.89
52w High
18.62
Price Metrics
Average Annual Return 19.89%
Standard Deviation of Annual Returns 75.76%
Max Drawdown -88%
Shares Statistics
Market Capitalization 2B USD
Shares Outstanding 128 600 000
Percentage of Shares Shorted 8.26%

AUPH Return Decomposition
Main factors of price return

Stock Splits

AUPH's latest stock split occurred on Nov 8, 2013

The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.

Before the split, AUPH traded at 0.035 per share. Afterward, the share price was about 2.6281.

The adjusted shares began trading on Nov 8, 2013. This was stock split number 2 in AUPH's history, following the previous one in Oct 23, 2013.

Pre-Split Price
1.75 0.035
Post-Split Price
2.6281
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett